Framework for Pre-Acquisition Assessment of Soft Tissue Robotic Surgery Systems

Overview

Robotic surgery offers enhanced ergonomics, visualization, and dexterity, improving clinical outcomes but with increased operative times and costs. The expiration of key patents has diversified available platforms, complicating acquisition decisions. This report presents a comprehensive, multi-domain framework integrating IDEAL and MCDA methodologies to guide healthcare facilities in selecting appropriate soft tissue robotic systems.

Background

Robotic surgery systems improve surgeon ergonomics and patient outcomes such as reduced blood loss and shorter hospital stays, though benefits vary by procedure. The expiration of foundational patents has led to multiple competing platforms with diverse capabilities and costs. Healthcare organizations face challenges in selecting systems aligned with their clinical needs, operational capacity, and financial constraints. A standardized, evidence-based framework is needed to support informed acquisition decisions amid increasing market complexity.

Data Highlights

Key Findings

• Robotic surgery improves surgeon ergonomics, visualization, and dexterity, leading to better clinical outcomes such as reduced blood loss and shorter hospital stays.
• Patent expirations have increased platform diversity, introducing multi-port, single-port, and laparoscopic assist systems with varying capabilities and costs.
• There is no standardized framework for robotic system selection; institutions require a structured approach considering clinical, operational, economic, and technological factors.
• The IDEAL Framework stages most current robotic platforms at early development phases (0–2b), with only established systems reaching advanced evaluation stages (3–4).
• Multi-Criteria Decision Analysis (MCDA) identifies eight critical domains for evaluation: clinical outcomes, patient relevance, hospital-specific factors, technology attributes, physician needs, economic implications, policy/regulatory considerations, and sustainability.
• Economic modeling highlights significant capital investment and ongoing maintenance costs, emphasizing the need for return-on-investment analysis tailored to institutional context.

Clinical Implications

Healthcare facilities should adopt a comprehensive, multi-domain evaluation framework when considering robotic surgery acquisitions to ensure alignment with clinical needs and institutional capabilities. Incorporating IDEAL and MCDA methodologies facilitates evidence-based decisions that balance clinical benefits, operational integration, and economic sustainability. This approach supports optimized platform selection tailored to specialty focus and procedural complexity.

Conclusion

The presented decision-making framework provides a structured, evidence-based approach to guide healthcare institutions in selecting soft tissue robotic surgery systems. By addressing clinical, operational, and economic domains, it enables informed acquisition decisions amid a rapidly evolving robotic surgery landscape.

References

1. IDEAL Framework -- Surgical Innovation Evaluation
2. Multi-Criteria Decision Analysis in Healthcare Technology Assessment
3. Robotic Surgery Outcomes and Cost Analyses
4. Patent Expirations and Market Impact on Robotic Platforms